Robuta

https://stanfordhealthcare.org/publications/790/790408.html 790408 | Stanford Health Care Onasemnogene Abeparvovec-xioi Gene-Replacement Therapy for Spinal Muscular Atrophy Type 1 (SMA1): Phase 3 US Study (STR1VE) Update stanfordhealthcare